Intestinal Carcinoma — Trials

Intestinal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,268 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 409
Recruiting: 235
Ph III recruiting: 16
Growth YoY: +6%
Industry share: 18%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (150)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05382377	NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors	unknown	Early Phase 1	18	jianming xuOTHER	1	May 19, 2022	clinicaltrials
NCT05287165	Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms	unknown	Early Phase 1	19	Beijing Immunochina Medical Science & Technology Co., Ltd.INDUSTRY	1	Mar 18, 2022	clinicaltrials